Literature DB >> 22992345

Pleuritis is a red flag for adult-onset Still's disease which may require biologic therapies.

Luca Quartuccio, Sara Salvin, Francesca Zuliani, Elisa Mansutti, Salvatore De Vita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22992345

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  4 in total

1.  A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?

Authors:  Francesca Dall'Ara; Micol Frassi; Angela Tincani; Paolo Airò
Journal:  Clin Rheumatol       Date:  2016-01-12       Impact factor: 2.980

2.  Still's disease with pleural effusion submitted to a pleurodesis.

Authors:  Jozélio Carvalho; Aaron Lerner
Journal:  Arch Rheumatol       Date:  2021-06-24       Impact factor: 1.472

3.  Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A.

Authors:  Hoshimi Kawaguchi; Hiroto Tsuboi; Mizuki Yagishita; Toshihiko Terasaki; Mayu Terasaki; Masaru Shimizu; Fumika Honda; Ayako Ohyama; Hiroyuki Takahashi; Haruka Miki; Masahiro Yokosawa; Hiromitsu Asashima; Shinya Hagiwara; Yuya Kondo; Isao Matsumoto; Takayuki Sumida
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

4.  Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Authors:  Serena Colafrancesco; Maria Manara; Alessandra Bortoluzzi; Teodora Serban; Gerolamo Bianchi; Luca Cantarini; Francesco Ciccia; Lorenzo Dagna; Marcello Govoni; Carlomaurizio Montecucco; Roberta Priori; Angelo Ravelli; Paolo Sfriso; Luigi Sinigaglia
Journal:  Arthritis Res Ther       Date:  2019-12-11       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.